Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Finalizes Initial $2.0M Convertible Note Issuance at Significant Discount

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.576
Mkt Cap
$2.506M
52W Low
$0.53
52W High
$11.109
Market data snapshot near publication time

summarizeSummary

SciSparc Ltd. finalized the issuance of an initial $2.0 million convertible promissory note for $1.8 million, representing a substantial and highly dilutive capital raise.


check_boxKey Events

  • Initial Convertible Note Finalized

    SciSparc Ltd. issued an initial convertible promissory note with a principal amount of $2.0 million to an institutional investor.

  • Discounted Purchase Price

    The note was purchased for $1.8 million, reflecting a 10% discount to its principal value, representing a substantial portion of the company's market capitalization.

  • Payment Contingent on Resale Registration

    The investor's obligation to pay the purchase price for the initial note is conditioned upon SciSparc filing a resale registration statement (Form F-3) covering the underlying shares and accompanying warrants.

  • Consulting Agreement Offset Option

    The company may elect to offset amounts due under a consulting agreement with the investor against the purchase price payable for the initial or any additional notes.


auto_awesomeAnalysis

This 6-K provides definitive terms for the initial tranche of a previously announced convertible note financing, finalizing the issuance of a $2.0 million principal note for $1.8 million. This represents a substantial discount and is highly dilutive given the company's small market capitalization. The payment for this note is contingent on the filing of a resale registration statement, and the company may offset amounts due under a consulting agreement, indicating complex financing arrangements. This capital infusion is critical for the company's operations but comes at a high cost to existing shareholders, following a series of dilutive capital raises.

At the time of this filing, SPRC was trading at $0.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.53 to $11.11. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SPRC - Latest Insights

SPRC
Apr 29, 2026, 4:20 PM EDT
Filing Type: 20-F
Importance Score:
9
SPRC
Mar 16, 2026, 8:21 AM EDT
Source: Reuters
Importance Score:
7
SPRC
Mar 12, 2026, 4:41 PM EDT
Filing Type: 6-K
Importance Score:
8
SPRC
Mar 12, 2026, 7:55 AM EDT
Source: GlobeNewswire
Importance Score:
7
SPRC
Mar 10, 2026, 9:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
SPRC
Mar 02, 2026, 8:08 AM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 17, 2026, 5:27 PM EST
Filing Type: F-3
Importance Score:
9
SPRC
Feb 17, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 12, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 03, 2026, 4:36 PM EST
Filing Type: F-3
Importance Score:
9